Summary:
The INSTRIDE studies are looking to see how well investigational insulin – designed to be as similar as possible to the diabetes medication insulin glargine (Lantus®) – works to control blood sugar levels.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have been diagnosed with Type 1 Diabetes
•
Have been taking Lantus® (insulin glargine) for at least
3 months
Qualified Participants May Receive:
Free study related diabetes care and compensation for time and travel.